We value your privacy
We use cookies to improve your experience and analyze traffic. By continuing, you consent to our use of cookies under GDPR, CCPA and other applicable laws. Privacy Policy
Cookie preferences
Choose which categories of cookies you allow. Strictly necessary cookies are always on.
Strictly necessary
Required for core site functionality, security and your session. Always active.
Analytics
Help us understand how visitors use the site (e.g. Google Analytics) so we can improve it.
Marketing
Used to measure campaigns and show you relevant ads on other sites (e.g. LinkedIn, Google Ads).
Poultry Vaccines market was valued at USD 1.95 Billion in 2022 and will reach USD 3.82 Billion by 2030, registering a CAGR of 10.8% for the forecast period 2023-2030. Download a free sample with data verified by Supriya Yadav
Based on product, the market is segmented into attenuated live vaccines, inactivated vaccines, recombinant vaccines, and others. The attenuated live vaccines segment is the dominating segment of the market. In comparison to other types of immunizations, these vaccines can cause the immune system to manufacture more antibodies. Additionally, immunization has a longer shelf life and offers defense against avian illnesses such as infectious bronchitis, infectious bursitis, and Newcastle disease. Additionally, the market is developing as a result of expanding R&D efforts, notably in the area of vaccination, to stop various outbreaks of the illnesses indicated above.
Attenuated Live Vaccines Poultry Vaccines Market Analysis
Disclaimer: The charts and graphs are for illustrative purposes only and do not represent actual market values. To access accurate quantitative data, please request a paid report or request free sample.
To learn more about market share and segmentation, request the free sample pages.
Competitor Analysis
October 2022
Zoetis expanded its poultry vaccine portfolio:
Zoetis expanded its poultry vaccine portfolio by introducing the recombinant vector vaccine Poulvac Procerta HVT-IBD-ND, which provides early/robust protection against Marek’s, infectious bursal and Newcastle disease viruses with one dose.
April 2022
Elanco launched a new animal healthcare company BiomEdit:
Elanco and Ginkgo Bioworks, in collaboration launched a new animal healthcare business called BiomEdit to create medications, dietary supplements, and disease-monitoring techniques for cattle. The new company, BiomEdit wants to address antibiotic resistance and increase sustainability.
January 2020
Boehringer Ingelheim announced the launch of a new vaccine:
Boehringer Ingelheim introduced the VAXXITEK HVT+IBD+ND vaccine to protect poultry against a number of illnesses, including Marek's disease, Newcastle disease, and infectious bursal disease (classic and variant kinds).
Click any bar or cell to request the full company profile
Top Companies (In no particular order)
2022 (A)
2023 (A)
2024 (A)
2025 (A)
Boehringer Ingelheim International GmbH
•••
•••
•••
•••
Phibro Animal Health Corporation
•••
•••
•••
•••
Ceva
•••
•••
•••
•••
Biovac
•••
•••
•••
•••
Zoetis
•••
•••
•••
•••
Merck & Co. Inc.
•••
•••
•••
•••
Elanco
•••
•••
•••
•••
Venkys India
•••
•••
•••
•••
Vaxxinova International BV
•••
•••
•••
•••
Hester Biosciences Limited
•••
•••
•••
•••
KM Biologics
•••
•••
•••
•••
Calier
•••
•••
•••
•••
We Provide Regional Breakdown of this Companies and Company specific to any Country, Region, Product/ service as well. We cover market share analysis for publicly listed companies as well as privately held companies, subject to data availability.
The global Poultry Vaccines market was valued at USD 1.95 Billion in 2022 and will reach USD 3.82 Billion by 2030, registering a CAGR of 10.8% for the forecast period 2023-2030.
What is the poultry vaccine market?
Poultry vaccines are used to prevent various diseases by significantly accelerating the immune system to produce antibodies to fight against invading organisms. The control and prevention of chicken diseases is significantly aided by poultry vaccinations. The bulk of vaccines made from chicken are designed to combat viral infections. These vaccinations are given in a variety of ways, including nasal, ocular, oral, intramuscular, in vivo, and subcutaneous. The growth of the poultry vaccines market is attributed to the increasing demand for poultry health along with rising poultry headcount and rising prevalence of zoonotic diseases. Additionally, the rising demand for poultry-related food products, government initiatives, rising meat consumption worldwide, cutting-edge manufacturing technologies for new vaccines, and rising poultry healthcare costs are all factors contributing to the growth of the market.
Analyst Conclusion
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Poultry Vaccines Market Analysis is witnessing significant growth in the near future.
In 2023, the Attenuated Live Vaccines
segment accounted for a notable share of the Poultry Vaccines Market Analysis.
Supriya is a Team Lead at Cognitive Market Research & Consulting, leading research initiatives and strategic intelligence projects across the Healthcare, Pharmaceuticals, and Medical Devices & Consumables sectors. With more than two years of experience in market research and data analysis, she plays a key role in helping organizations navigate complex healthcare ecosystems, identify emerging opportunities, and make informed business decisions through data-driven insights and market intelligence.
Combining expertise in both primary and secondary research methodologies with a strong academic foundation in Marketing and Finance, Supriya oversees the execution of market assessments, competitive intelligence studies, forecasting models, stakeholder interviews, trend analysis, and custom consulting engagements. She collaborates with healthcare providers, pharmaceutical manufacturers, medical device companies, industry experts, and other key stakeholders to gather firsthand market perspectives while validating findings through extensive research. Her ability to interpret clinical, commercial, and market data enables clients to better understand industry developments, regulatory influences, innovation trends, and competitive dynamics.
In her leadership role, she manages end-to-end research projects and guides cross-functional teams in delivering high-quality market reports, consulting solutions, and strategic studies. Her expertise in market estimation, forecasting, and analytical modeling helps organizations evaluate market potential, assess growth opportunities, strengthen competitive positioning, and support strategic planning initiatives. By transforming complex healthcare and life sciences data into actionable business intelligence, she enables clients to make confident decisions in rapidly evolving market environments.
Driven by a passion for healthcare innovation and continuous professional development, Supriya remains committed to staying ahead of industry trends, technological advancements, and changing market conditions. Her leadership, analytical mindset, and dedication to research excellence help organizations mitigate risks, capitalize on emerging opportunities, and achieve sustainable growth across the global healthcare and life sciences landscape.
Poultry Vaccines Market Analysis market size and growth rate is provided in the report covering 2021-2025 historical and 2025-2033 forecast data.
Major factors including drivers, restraints, opportunities and challenges are analyzed with detailed insights.
Top manufacturers Boehringer Ingelheim International GmbH, Phibro Animal Health Corporation, Ceva, Biovac, Zoetis, Merck & Co. Inc., Elanco, Venkys India, Vaxxinova International BV, Hester Biosciences Limited, KM Biologics, Calier and others are profiled in the report.
Segments include Product, Application and additional sub-segments.
Regional analysis covers all major markets. The report identifies the dominant region and provides country-level data.
Sample pages can be obtained on demand from the website. 24/7 chat support and direct call services are available.
★ Reviews
Rate this report
Poultry Vaccines Market Analysis — Table of Contents
Disclaimer:
This is just a redacted sample pages of the actual deliverable report and only for representative purposes
Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
If applicable; On Request Volume Data will also be provided (at an Additional Cost).
Report Scope
Product
Attenuated Live Vaccines, Inactivated Vaccines, Recombinant Vaccines, Others
12.14.2 AI-Driven Transformation of Industry Value Chain
12.14.3 Evolution of Business Models & Revenue Streams
12.14.4 AI-Driven Product, Service & Innovation Transformation
12.14.5 Customer Behavior, AI Adoption & Future Market Evolution
Chapter 13. TOP 10 Country Analysis
13.1 Country 1
13.2 Country 2
13.3 Country 3
13.4 Country 4
13.5 Country 5
13.6 Country 6
13.7 Country 7
13.8 Country 8
13.9 Country 9
13.10 Country 10
Chapter 14. Research Findings
14.1 Key Takeaways
14.2 Analyst Point of View
14.3 Assumptions and Acronyms
Chapter 15. Research Methodology and Sources
15.1 Primary Data Collection
15.1.1 Steps for Primary Data Collection
15.1.1.1 Identification of KOL
15.1.2 Backward Integration
15.1.3 Forward Integration
15.1.4 How Primary Research Help Us
15.1.5 Modes of Primary Research
15.2 Secondary Research
15.2.1 How Secondary Research Help Us
15.2.2 Sources of Secondary Research
15.3 Data Validation
15.3.1 Data Triangulation
15.4 Data Representation
Athenaeum AI Dashboard
Research Framework · 70:30 Primary:Secondary
Our Proprietary Methodology
Cognitive Market Research and Consulting "The Full Truth" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Supriya Yadav and team for the Poultry Vaccines Market Analysis Market analysis.
01
Primary Intelligence Gathering
Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.
02
Secondary Data Triangulation
Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.
03
Expert Validation Protocol
Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.
04
Athenaeum AI Processing
Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.
05
Editorial & QA Review
Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.
To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.
Latest News about Poultry Vaccines Market
10 Apr 2024agriculturedive.com
Cal Maine ceases operations at Texas facility after bird flu detected
Cal-Maine Foods facility in Parmer County, Texas, has temporarily halted operations due to highly pathogenic avian influenza detected on the premises. The company depopulated around 1.6 million laying hens and 337,000 pullets, or 3.6% of its total flock, as of March 2. Texas Agriculture Commissioner Sid Miller emphasized the need for producers to practice heightened biosecurity measures due to the rapid spread of the virus. The detection comes as a peculiar strain of avian influenza affects dairy cow herds in Texas, Kansas, Michigan, and other parts of the country. There is now little risk to the public, and national and state organizations are updating their guidelines as new information becomes available. Bird flu has already caused Cal-Maine to suspend production; a comparable outbreak occurred in Kansas during the third quarter that ended on March 2. Due to a "significant decrease" in egg prices, the company reported net sales of $703 million in the third quarter, which was 30% less than the same period last year. The most recent quarter's net income was $146.7 million, while sales volumes rose by 3% over the previous one.
The Three Pillars of End-to-End Market Research Services
We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the Poultry Vaccines Market Analysis market.
Service 01
Market Survey
B2BB2C
Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the poultry vaccines market analysis ecosystem — validated by our global panel of 10,000+ industrial respondents.
What's Included
Buyer intent & sentiment analysis
Purchase cycle mapping
Price sensitivity research
Channel preference profiling
Competitive perception study
Most Requested
Service 02
Customized Market Data & Reports
CustomReady Report
Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.
What's Included
Ready syndicate report
Custom data scope & segmentation
Excel quantitative models
Board-ready PPT with key findings
Secure cloud portal access
Service 03
Strategic Consultation
With SurveyWith Report
Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.
Tell us the specific segments, regions, or companies you need — and we will tailor the deliverable to your requirements.
Why Trust Us
What these certifications mean to usA market figure is only as reliable as the system that produced it. That is why our accreditations cover the whole chain, not just the research step. ESOMAR and MRSI membership binds us to the professional codes that govern how respondents are recruited and how findings may be represented. ISO 20252 governs the research process itself; ISO 9001 and our quality control certification govern how consistently we repeat it. ISO 27001 and ISO 27701, alongside our GDPR, CCPA and DPDP compliance, govern what happens to your brief and your data once it reaches us; because a confidential scope is often more sensitive than the deliverable. ISO 14001, our D-U-N-S registration, Chamber of Commerce membership and DMCA protection speak to how the company itself is run and how its work is safeguarded.Our Clutch and Trustpilot profiles are deliberately listed next to them. They are the only signals on this page we do not issue ourselves, and they are the ones we would check first if we were you.
I enjoyed reviewing all the contents of the report. I am wondering if you can generate similar reports for Orlistat and Mounjaro as you have provided for o…
